Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stabilitySjoerd H. van der Burg, C J Melief, Marjan J.W. Visseren et al.|The Journal of Immunology|1996Cited by 396
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.Maaike E. Ressing, W. Martin Kast, Cornelis J.M. Melief et al.|The Journal of Immunology|1995Cited by 386
Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.W. Martin Kast, Alessandro Sette, Remco M.P. Brandt et al.|The Journal of Immunology|1994Cited by 345
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I–II trialWillemien J. van Driel, J. Baptist Trimbos, Rienk Offringa et al.|European Journal of Cancer|1999Cited by 230
Detection of T Helper Responses, But Not of Human Papillomavirus-Specific Cytotoxic T Lymphocyte Responses, After Peptide Vaccination of Patients With Cervical CarcinomaMaaike E. Ressing, Cornelis J.M. Melief, Willemien J. van Driel et al.|Journal of Immunotherapy|2000Cited by 172